Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 1313, pseudogene (RNU6-1313P)** is a pseudogene located on human chromosome 17q21.33 and categorized as a small nuclear RNA (snRNA) pseudogene[3]. It is derived from the highly conserved U6 small nuclear RNA (U6 snRNA), which plays a crucial role in catalyzing pre-mRNA splicing as part of the spliceosome complex[1][5]. However, as a pseudogene, RNU6-1313P does not encode a functional product; instead, it represents a genomic remnant generated through retrotransposition events such as those mediated by LINE elements, and is not believed to be transcribed into a functional U6 snRNA molecule[7]. U6 snRNA pseudogenes like RNU6-1313P are common in the human genome and serve mainly as markers of transpositional activity rather than as functional targets. There is no evidence that RNU6-1313P has independent biological or disease relevance, nor is it a druggable or therapeutic target[7][3]. \n\n**Clarification:** This entry is considered incorrect as a therapeutic target because:\n- It is a *pseudogene* and not a protein, enzyme, receptor, transporter, or other classical drug target.\n- It is not known to produce a functional RNA or protein, nor to have an independent biological function.\n- There are no known drugs, biomarkers, or disease associations specifically tied to RNU6-1313P[3][7][4].\n\nFor structured biomedical purposes, this should be flagged as *not a functional or druggable target* but rather as a non-functional RNA gene remnant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1313, pseudogene (RNU6-1313P).